CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards
CSL's Broadmeadows facility has been recognized as the Overall Winner of the 2025 Facility of the Year Award by the International Society for Pharmaceutical Engineering (ISPE).
The facility blends Pharma 4.0 principles with sustainable design to transform plasma manufacturing, setting new standards in responsible innovation.
- Purpose-built to optimize the production of plasma-derived therapies
- Combines cutting-edge technologies with a pioneering hybrid manufacturing platform
- Treats conditions such as immunodeficiencies, neurological disorders, and burns
CSL's base fractionation facility in Broadmeadows, Australia has been recognised as the Overall Winner of the 2025 Facility of the Year Award (FOYA) by the International Society for Pharmaceutical Engineering (ISPE).
Author's summary: CSL wins Facility of the Year Award for innovative plasma manufacturing.
More News
- Disparities in PsA Burden and Treatment Linked to Geographic and Social Factors
- Deandre Ayton claims Los Angeles Lakers superstars ‘troll him’ to get him going
- Meet the Next Generation of Physician Leaders at Rutgers Health
- Poll Tracker: Honduras' 2025 Presidential Election
- ICYMI: AAO 2025 showcases new technologies and continued research | Ophthalmology Times - Clinical Insights for Eye Specialists
- CRC Screening Improvements Decrease Mortality, but Disparities Persist
- Why Experienced Lawyers Matter in a Personal Injury Case | NorthPennNow
- Elon Musk could step down if Tesla pay plan is rejected
- Landmark New Report Shows Canadian Lobbyists Represent Major Polluters Alongside Environmental Groups
- Racial Disparities Persist in Victim Compensation for Homicide Survivors